Vinay Prasad leaves FDA after less than three months amid Duchenne gene therapy controversy Post date 31 July 2025 ← Helen Salisbury: GPs are unhappy about new neighbourhood plans → Starvation is a lifelong sentence: Gaza’s civilians must be protected